Highly precise radiopharmaceuticals can be used to effectively diagnose or treat tumors expressing specific receptors on their surface. Watch the video to learn more about their mode of action (MoA).

Learn more about targeted radiopharmaceutical therapy and the mechanism of action of radiotherapeutic agents used for the treatment of tumors expressing specific receptors on their surface.

Prof. Capdevila shares his views on the potential impact of ongoing phase III studies on the guidelines for managing well-differentiated neuroendocrine tumors.